NACL Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 29, 2025, 6:58 am

Competitors of NACL Industries Ltd

All Competitor Stocks of NACL Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 4:40 pm

Below is a detailed analysis of the quarterly data for NACL Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 448.00 Cr.. The value appears strong and on an upward trend. It has increased from 201.00 Cr. (Mar 2025) to 448.00 Cr., marking an increase of 247.00 Cr..
• For Expenses, as of Jun 2025, the value is 410.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 275.00 Cr. (Mar 2025) to 410.00 Cr., marking an increase of 135.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from -74.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 112.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from -37.00% (Mar 2025) to 8.00%, marking an increase of 45.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 29.00 Cr..
• For Interest, as of Jun 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from -66.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 84.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from -24.00% (Mar 2025) to 27.00%, marking an increase of 51.00%.
• For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from -50.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 63.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.65. The value appears strong and on an upward trend. It has increased from -2.49 (Mar 2025) to 0.65, marking an increase of 3.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:48 am

Growth

Last Updated: September 5, 2025, 11:25 am

Balance Sheet

Last Updated: October 10, 2025, 2:35 pm

Below is a detailed analysis of the balance sheet data for NACL Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 407.00 Cr.. The value appears to be declining and may need further review. It has decreased from 491.00 Cr. (Mar 2024) to 407.00 Cr., marking a decrease of 84.00 Cr..
• For Borrowings, as of Mar 2025, the value is 399.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 789.00 Cr. (Mar 2024) to 399.00 Cr., marking a decrease of 390.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 437.00 Cr.. The value appears to be improving (decreasing). It has decreased from 518.00 Cr. (Mar 2024) to 437.00 Cr., marking a decrease of 81.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,263.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,818.00 Cr. (Mar 2024) to 1,263.00 Cr., marking a decrease of 555.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 439.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 439.00 Cr..
• For CWIP, as of Mar 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2024) to 43.00 Cr., marking a decrease of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 766.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,318.00 Cr. (Mar 2024) to 766.00 Cr., marking a decrease of 552.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,263.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,818.00 Cr. (Mar 2024) to 1,263.00 Cr., marking a decrease of 555.00 Cr..

Notably, the Reserves (407.00 Cr.) exceed the Borrowings (399.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for NACL Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -4.62. This value is below the healthy minimum of 5. It has decreased from -2.96 (Mar 24) to -4.62, marking a decrease of 1.66.
• For Diluted EPS (Rs.), as of Mar 25, the value is -4.62. This value is below the healthy minimum of 5. It has decreased from -2.95 (Mar 24) to -4.62, marking a decrease of 1.67.
• For Cash EPS (Rs.), as of Mar 25, the value is -3.15. This value is below the healthy minimum of 3. It has decreased from -1.64 (Mar 24) to -3.15, marking a decrease of 1.51.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.23. It has decreased from 25.66 (Mar 24) to 21.23, marking a decrease of 4.43.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.23. It has decreased from 25.66 (Mar 24) to 21.23, marking a decrease of 4.43.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 61.36. It has decreased from 89.29 (Mar 24) to 61.36, marking a decrease of 27.93.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -2.73. This value is below the healthy minimum of 2. It has decreased from 1.28 (Mar 24) to -2.73, marking a decrease of 4.01.
• For PBIT / Share (Rs.), as of Mar 25, the value is -4.17. This value is below the healthy minimum of 0. It has decreased from -0.08 (Mar 24) to -4.17, marking a decrease of 4.09.
• For PBT / Share (Rs.), as of Mar 25, the value is -5.94. This value is below the healthy minimum of 0. It has decreased from -3.88 (Mar 24) to -5.94, marking a decrease of 2.06.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -4.60. This value is below the healthy minimum of 2. It has decreased from -3.01 (Mar 24) to -4.60, marking a decrease of 1.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.58. This value is below the healthy minimum of 2. It has decreased from -2.96 (Mar 24) to -4.58, marking a decrease of 1.62.
• For PBDIT Margin (%), as of Mar 25, the value is -4.44. This value is below the healthy minimum of 10. It has decreased from 1.43 (Mar 24) to -4.44, marking a decrease of 5.87.
• For PBIT Margin (%), as of Mar 25, the value is -6.79. This value is below the healthy minimum of 10. It has decreased from -0.09 (Mar 24) to -6.79, marking a decrease of 6.70.
• For PBT Margin (%), as of Mar 25, the value is -9.68. This value is below the healthy minimum of 10. It has decreased from -4.35 (Mar 24) to -9.68, marking a decrease of 5.33.
• For Net Profit Margin (%), as of Mar 25, the value is -7.48. This value is below the healthy minimum of 5. It has decreased from -3.37 (Mar 24) to -7.48, marking a decrease of 4.11.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -7.46. This value is below the healthy minimum of 8. It has decreased from -3.31 (Mar 24) to -7.46, marking a decrease of 4.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is -21.57. This value is below the healthy minimum of 15. It has decreased from -11.52 (Mar 24) to -21.57, marking a decrease of 10.05.
• For Return on Capital Employeed (%), as of Mar 25, the value is -15.65. This value is below the healthy minimum of 10. It has decreased from -0.24 (Mar 24) to -15.65, marking a decrease of 15.41.
• For Return On Assets (%), as of Mar 25, the value is -7.29. This value is below the healthy minimum of 5. It has decreased from -3.23 (Mar 24) to -7.29, marking a decrease of 4.06.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has decreased from 0.29 (Mar 24) to 0.19, marking a decrease of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.92. This value is within the healthy range. It has decreased from 1.54 (Mar 24) to 0.92, marking a decrease of 0.62.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.80. It has decreased from 0.95 (Mar 24) to 0.80, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1.5. It has decreased from 1.13 (Mar 24) to 0.97, marking a decrease of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.60, marking a decrease of 0.22.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 4. It has decreased from 2.95 (Mar 24) to 2.57, marking a decrease of 0.38.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -8.43 (Mar 24) to 0.00, marking an increase of 8.43.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -15.70 (Mar 24) to 0.00, marking an increase of 15.70.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 108.43 (Mar 24) to 0.00, marking a decrease of 108.43.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 115.70 (Mar 24) to 0.00, marking a decrease of 115.70.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -0.84. This value is below the healthy minimum of 3. It has decreased from 0.33 (Mar 24) to -0.84, marking a decrease of 1.17.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.87. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to -0.87, marking a decrease of 1.07.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,384.20. It has increased from 1,848.80 (Mar 24) to 2,384.20, marking an increase of 535.40.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.93, marking an increase of 0.89.
• For EV / EBITDA (X), as of Mar 25, the value is -43.48. This value is below the healthy minimum of 5. It has decreased from 72.28 (Mar 24) to -43.48, marking a decrease of 115.76.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has increased from 0.63 (Mar 24) to 1.66, marking an increase of 1.03.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 108.43 (Mar 24) to 0.00, marking a decrease of 108.43.
• For Price / BV (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 2.20 (Mar 24) to 4.79, marking an increase of 2.59.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has increased from 0.63 (Mar 24) to 1.66, marking an increase of 1.03.
• For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to -0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness